色控传媒 NEXT
The Premier Clinical Trials Conference Series

Discover Your NEXT Experience.

色控传媒 NEXT is the crossroads of the life sciences industry—where leaders and organizations meet to map the future.

 

色控传媒 NEXT 
The Premier Clinical Trials Conference Series
Discover Your NEXT Experience.
色控传媒 NEXT is the crossroads of the life sciences industry—where leaders and organizations meet to map the future. 

 

The Story Behind 色控传媒 NEXT

NEXT started back in 2006—although it went by a different name then. The first-ever 色控传媒 User Group (known as MUG) took place in Thousand Oaks, California. This small forum gave customers the chance to ask questions and hear more about 色控传媒’s suite of solutions.

As the conference grew, so did the networking opportunities. What was once a 30+ strong gathering expanded to 700+ attendees and multiple locations. MUG became NEXT—a new, future-forward event that brings together the life sciences industry to learn, connect, and engage.

Why Attend 色控传媒 NEXT?

色控传媒 NEXT is more than a clinical trials conference—it’s an experience built to captivate the greatest life sciences minds. Don’t miss your chance to join hundreds of leaders across pharma, biotech, medtech, CROs, and research sites who are responsible for addressing key issues in digital health.

  • Learn from the world’s experts as we explore the latest advancements.
  • Network with colleagues and peers who have faced similar challenges.
  • Discover 色控传媒’s latest innovations and product roadmap.

Registration is free for our customers and qualified members of the life sciences community.

The 色控传媒 NEXT City Series

The next step in the growth of our signature event is a global reimagining. The NEXT City Series brings the premier clinical trials conference experience to customers around the world.

We’re taking NEXT on the road across numerous countries and cities. From metropolitan hubs to sunny shores, you don’t want to miss this immersive industry event.

Click on the city you’re interested in below to learn more and register.